Rhythm Pharmaceuticals Inc (RYTM)
59.91
-0.03
(-0.05%)
USD |
NASDAQ |
Nov 25, 16:00
59.91
0.00 (0.00%)
After-Hours: 20:00
Rhythm Pharmaceuticals Shareholders Equity (Quarterly): 11.22M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 11.22M |
| June 30, 2024 | 179.50M |
| March 31, 2024 | 61.58M |
| December 31, 2023 | 169.76M |
| September 30, 2023 | 197.47M |
| June 30, 2023 | 182.28M |
| March 31, 2023 | 219.76M |
| December 31, 2022 | 264.26M |
| September 30, 2022 | 281.20M |
| June 30, 2022 | 195.63M |
| March 31, 2022 | 235.77M |
| December 31, 2021 | 284.15M |
| September 30, 2021 | 322.26M |
| June 30, 2021 | 351.69M |
| March 31, 2021 | 380.95M |
| December 31, 2020 | 166.53M |
| Date | Value |
|---|---|
| September 30, 2020 | 196.94M |
| June 30, 2020 | 225.75M |
| March 31, 2020 | 253.10M |
| December 31, 2019 | 281.02M |
| September 30, 2019 | 149.12M |
| June 30, 2019 | 181.47M |
| March 31, 2019 | 220.49M |
| December 31, 2018 | 246.26M |
| September 30, 2018 | 269.64M |
| June 30, 2018 | 284.32M |
| March 31, 2018 | 133.66M |
| December 31, 2017 | 144.79M |
| September 30, 2017 | -51.86M |
| June 30, 2017 | 35.77M |
| December 31, 2016 | -32.70M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
11.22M
Minimum
Sep 2024
380.95M
Maximum
Mar 2021
223.04M
Average
222.76M
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly and Co | 14.24B |
| TG Therapeutics Inc | 192.16M |
| Regeneron Pharmaceuticals Inc | 29.33B |
| Voyager Therapeutics Inc | 330.31M |
| Krystal Biotech Inc | 885.85M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 363.57M |
| Total Liabilities (Quarterly) | 352.36M |
| Current Ratio | 3.487 |